Windtree Therapeutics Inc (NASDAQ: WINT) kicked off on Friday, down -2.54% from the previous trading day, before settling in for the closing price of $0.13. Over the past 52 weeks, WINT has traded in a range of $0.13-$14.75.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company slipped by -25.00% over the past five years. While this was happening, its average annual earnings per share was recorded 94.00%. With a float of $10.99 million, this company’s outstanding shares have now reached $11.05 million.
Let’s look at the performance matrix of the company that is accounted for 15 employees. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Windtree Therapeutics Inc (WINT) Insider and Institutional Ownership
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Windtree Therapeutics Inc is 0.52%, while institutional ownership is 1.48%. The most recent insider transaction that took place on Oct 08 ’24, was worth 4,942. In this transaction President and CEO of this company bought 5,431 shares at a rate of $0.91, taking the stock ownership to the 8,638 shares.
Windtree Therapeutics Inc (WINT) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 94.00% per share during the next fiscal year.
Windtree Therapeutics Inc (NASDAQ: WINT) Trading Performance Indicators
Take a look at Windtree Therapeutics Inc’s (WINT) current performance indicators. Last quarter, stock had a quick ratio of 0.27.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -18.63, a number that is poised to hit -0.35 in the next quarter and is forecasted to reach -2.86 in one year’s time.
Technical Analysis of Windtree Therapeutics Inc (WINT)
Windtree Therapeutics Inc (NASDAQ: WINT) saw its 5-day average volume 4.07 million, a negative change from its year-to-date volume of 7.92 million. As of the previous 9 days, the stock’s Stochastic %D was 4.57%. Additionally, its Average True Range was 0.04.
During the past 100 days, Windtree Therapeutics Inc’s (WINT) raw stochastic average was set at 0.11%, which indicates a significant decrease from 2.06% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 59.39% in the past 14 days, which was lower than the 141.66% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.3400, while its 200-day Moving Average is $3.2471. Nevertheless, the first resistance level for the watch stands at $0.1364 in the near term. At $0.1422, the stock is likely to face the second major resistance level. The third major resistance level sits at $0.1464. If the price goes on to break the first support level at $0.1264, it is likely to go to the next support level at $0.1222. The third support level lies at $0.1164 if the price breaches the second support level.
Windtree Therapeutics Inc (NASDAQ: WINT) Key Stats
The company with the Market Capitalisation of 1.44 million has total of 11,049K Shares Outstanding. Its annual sales at the moment are 0 K in contrast with the sum of -20,290 K annual income. Company’s last quarter sales were recorded 0 K and last quarter income was -2,750 K.
